Filing Details
- Accession Number:
- 0001608901-20-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-04 11:45:53
- Reporting Period:
- 2020-02-03
- Accepted Time:
- 2020-02-04 11:45:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1208261 | Immune Pharmaceuticals Inc | IMNPQ | Pharmaceutical Preparations (2834) | 521841431 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1608901 | S. Anthony Fiorino | C/O Immune Pharmaceuticals Inc. 1 Bridge Plaza North, Suite 270 Fort Lee NJ 07024 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-03 | 75,000 | $0.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
